nodes	percent_of_prediction	percent_of_DWPC	metapath
Didanosine—SLC29A2—prostate gland—prostate cancer	0.0199	0.212	CbGeAlD
Didanosine—PNP—renal system—prostate cancer	0.0181	0.193	CbGeAlD
Didanosine—PNP—bone marrow—prostate cancer	0.0137	0.146	CbGeAlD
Didanosine—Zalcitabine—CYP3A43—prostate cancer	0.0135	0.736	CrCbGaD
Didanosine—SLC29A1—prostate gland—prostate cancer	0.00987	0.105	CbGeAlD
Didanosine—SLC29A1—renal system—prostate cancer	0.00672	0.0717	CbGeAlD
Didanosine—SLC29A1—urethra—prostate cancer	0.00661	0.0705	CbGeAlD
Didanosine—PNP—Paclitaxel—Cabazitaxel—prostate cancer	0.00656	0.266	CbGdCrCtD
Didanosine—SLC29A2—lymph node—prostate cancer	0.00635	0.0678	CbGeAlD
Didanosine—SLC29A1—Fluoropyrimidine Activity—UMPS—prostate cancer	0.00587	0.0467	CbGpPWpGaD
Didanosine—PNP—Nucleotide metabolism—UMPS—prostate cancer	0.00561	0.0447	CbGpPWpGaD
Didanosine—SLC29A1—bone marrow—prostate cancer	0.00508	0.0542	CbGeAlD
Didanosine—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A3—prostate cancer	0.00438	0.0349	CbGpPWpGaD
Didanosine—SLC29A1—testis—prostate cancer	0.00435	0.0464	CbGeAlD
Didanosine—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A1—prostate cancer	0.00357	0.0285	CbGpPWpGaD
Didanosine—SLC29A1—Fluoropyrimidine Activity—CYP2A6—prostate cancer	0.00355	0.0283	CbGpPWpGaD
Didanosine—Zalcitabine—CYP3A5—prostate cancer	0.00337	0.184	CrCbGaD
Didanosine—SLC29A1—lymph node—prostate cancer	0.00315	0.0336	CbGeAlD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC7A1—prostate cancer	0.00283	0.0225	CbGpPWpGaD
Didanosine—PNP—Paclitaxel—Docetaxel—prostate cancer	0.00272	0.111	CbGdCrCtD
Didanosine—PNP—Estradiol valerate/Dienogest—Estrone—prostate cancer	0.00246	0.0998	CbGdCrCtD
Didanosine—SLC29A1—Fluoropyrimidine Activity—TYMS—prostate cancer	0.00232	0.0185	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	0.00223	0.0178	CbGpPWpGaD
Didanosine—PNP—Nucleotide metabolism—TYMS—prostate cancer	0.00222	0.0177	CbGpPWpGaD
Didanosine—SLC29A1—Fluoropyrimidine Activity—ERCC2—prostate cancer	0.00215	0.0172	CbGpPWpGaD
Didanosine—PNP—Testosterone Propionate—Estradiol valerate/Dienogest—prostate cancer	0.00209	0.0848	CbGdCrCtD
Didanosine—SLC29A1—Fluoropyrimidine Activity—MTHFR—prostate cancer	0.00202	0.0161	CbGpPWpGaD
Didanosine—PNP—Fulvestrant—Estradiol—prostate cancer	0.00199	0.0807	CbGdCrCtD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC7A1—prostate cancer	0.00196	0.0156	CbGpPWpGaD
Didanosine—PNP—Estradiol valerate/Dienogest—Estradiol—prostate cancer	0.00186	0.0756	CbGdCrCtD
Didanosine—PNP—Estradiol valerate/Dienogest—Ethinyl Estradiol—prostate cancer	0.00182	0.0738	CbGdCrCtD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.00177	0.0141	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.00177	0.0141	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	0.00155	0.0123	CbGpPWpGaD
Didanosine—Zalcitabine—CYP3A4—prostate cancer	0.00146	0.0798	CrCbGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.00144	0.0115	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.00144	0.0114	CbGpPWpGaD
Didanosine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A1—prostate cancer	0.00136	0.0109	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.00123	0.0098	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.00123	0.0098	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.00117	0.00935	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.00114	0.00904	CbGpPWpGaD
Didanosine—PNP—Metabolism—HAO1—prostate cancer	0.00109	0.00867	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.000998	0.00795	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000995	0.00793	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000925	0.00737	CbGpPWpGaD
Didanosine—PNP—Daunorubicin—Epirubicin—prostate cancer	0.000912	0.037	CbGdCrCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000902	0.00718	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000902	0.00718	CbGpPWpGaD
Didanosine—PNP—Metabolism—CSAD—prostate cancer	0.000888	0.00707	CbGpPWpGaD
Didanosine—PNP—Metabolism—GRHL1—prostate cancer	0.000888	0.00707	CbGpPWpGaD
Didanosine—PNP—Metabolism—CBR1—prostate cancer	0.000888	0.00707	CbGpPWpGaD
Didanosine—PNP—Metabolism—ADI1—prostate cancer	0.000888	0.00707	CbGpPWpGaD
Didanosine—PNP—Metabolism—TST—prostate cancer	0.000888	0.00707	CbGpPWpGaD
Didanosine—PNP—Metabolism—PSAT1—prostate cancer	0.000888	0.00707	CbGpPWpGaD
Didanosine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—prostate cancer	0.000878	0.00699	CbGpPWpGaD
Didanosine—PNP—Danazol—Ethinyl Estradiol—prostate cancer	0.000867	0.0352	CbGdCrCtD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.000856	0.00682	CbGpPWpGaD
Didanosine—PNP—Daunorubicin—Doxorubicin—prostate cancer	0.000844	0.0343	CbGdCrCtD
Didanosine—PNP—Metabolism—UGT2B17—prostate cancer	0.000825	0.00657	CbGpPWpGaD
Didanosine—PNP—Metabolism—UGT2B15—prostate cancer	0.000825	0.00657	CbGpPWpGaD
Didanosine—PNP—Metabolism—GRHPR—prostate cancer	0.000825	0.00657	CbGpPWpGaD
Didanosine—PNP—Metabolism—CKMT2—prostate cancer	0.000825	0.00657	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.000813	0.00648	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000787	0.00627	CbGpPWpGaD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC7A1—prostate cancer	0.000783	0.00624	CbGpPWpGaD
Didanosine—PNP—Norethindrone—Ethinyl Estradiol—prostate cancer	0.000781	0.0317	CbGdCrCtD
Didanosine—PNP—Metabolism—AOX1—prostate cancer	0.000776	0.00618	CbGpPWpGaD
Didanosine—PNP—Metabolism—MBTPS1—prostate cancer	0.000776	0.00618	CbGpPWpGaD
Didanosine—PNP—Metabolism—RFK—prostate cancer	0.000776	0.00618	CbGpPWpGaD
Didanosine—PNP—Metabolism—GSTM3—prostate cancer	0.000776	0.00618	CbGpPWpGaD
Didanosine—PNP—Metabolism—SULT2B1—prostate cancer	0.000776	0.00618	CbGpPWpGaD
Didanosine—PNP—Metabolism—NAGLU—prostate cancer	0.000776	0.00618	CbGpPWpGaD
Didanosine—PNP—Metabolism—PGAM2—prostate cancer	0.000776	0.00618	CbGpPWpGaD
Didanosine—SLC29A1—Fluoropyrimidine Activity—TP53—prostate cancer	0.000769	0.00612	CbGpPWpGaD
Didanosine—PNP—Metabolism—AMACR—prostate cancer	0.000735	0.00586	CbGpPWpGaD
Didanosine—PNP—Metabolism—CYP3A43—prostate cancer	0.000735	0.00586	CbGpPWpGaD
Didanosine—PNP—Metabolism—DEGS1—prostate cancer	0.000735	0.00586	CbGpPWpGaD
Didanosine—PNP—Metabolism—NAT1—prostate cancer	0.000735	0.00586	CbGpPWpGaD
Didanosine—PNP—Metabolism—SRD5A2—prostate cancer	0.000735	0.00586	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000732	0.00583	CbGpPWpGaD
Didanosine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—prostate cancer	0.000716	0.0057	CbGpPWpGaD
Didanosine—PNP—Metabolism—HSD17B1—prostate cancer	0.000702	0.00559	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000675	0.00538	CbGpPWpGaD
Didanosine—Anaphylactoid reaction—Epirubicin—prostate cancer	0.000664	0.000899	CcSEcCtD
Didanosine—Agranulocytosis—Capecitabine—prostate cancer	0.000663	0.000898	CcSEcCtD
Didanosine—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000663	0.000898	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Estradiol—prostate cancer	0.000662	0.000897	CcSEcCtD
Didanosine—Nausea—Ethinyl Estradiol—prostate cancer	0.000661	0.000896	CcSEcCtD
Didanosine—Hepatic failure—Doxorubicin—prostate cancer	0.000661	0.000896	CcSEcCtD
Didanosine—Hepatitis—Docetaxel—prostate cancer	0.000659	0.000893	CcSEcCtD
Didanosine—Hypoglycaemia—Epirubicin—prostate cancer	0.000658	0.000892	CcSEcCtD
Didanosine—Asthenia—Goserelin—prostate cancer	0.000658	0.000891	CcSEcCtD
Didanosine—Hypoaesthesia—Docetaxel—prostate cancer	0.000655	0.000888	CcSEcCtD
Didanosine—Paraesthesia—Estradiol—prostate cancer	0.000652	0.000884	CcSEcCtD
Didanosine—Asthenia—Conjugated Estrogens—prostate cancer	0.000651	0.000883	CcSEcCtD
Didanosine—Pruritus—Goserelin—prostate cancer	0.000648	0.000879	CcSEcCtD
Didanosine—Anorexia—Mitoxantrone—prostate cancer	0.000645	0.000875	CcSEcCtD
Didanosine—Renal failure acute—Doxorubicin—prostate cancer	0.000644	0.000872	CcSEcCtD
Didanosine—Pruritus—Conjugated Estrogens—prostate cancer	0.000642	0.00087	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000641	0.00511	CbGpPWpGaD
Didanosine—Hyperglycaemia—Prednisone—prostate cancer	0.00064	0.000868	CcSEcCtD
Didanosine—Dyspepsia—Estradiol—prostate cancer	0.00064	0.000867	CcSEcCtD
Didanosine—Hepatitis—Capecitabine—prostate cancer	0.000638	0.000864	CcSEcCtD
Didanosine—Anaemia—Etoposide—prostate cancer	0.000638	0.000864	CcSEcCtD
Didanosine—Hypoaesthesia—Capecitabine—prostate cancer	0.000635	0.00086	CcSEcCtD
Didanosine—Decreased appetite—Estradiol—prostate cancer	0.000632	0.000856	CcSEcCtD
Didanosine—Diarrhoea—Goserelin—prostate cancer	0.000627	0.00085	CcSEcCtD
Didanosine—PNP—Metabolism—HPGD—prostate cancer	0.000625	0.00498	CbGpPWpGaD
Didanosine—PNP—Metabolism—B4GALT4—prostate cancer	0.000625	0.00498	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000625	0.00498	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000625	0.00498	CbGpPWpGaD
Didanosine—Renal impairment—Doxorubicin—prostate cancer	0.000624	0.000846	CcSEcCtD
Didanosine—Malaise—Etoposide—prostate cancer	0.000622	0.000843	CcSEcCtD
Didanosine—PNP—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.000621	0.0253	CbGdCrCtD
Didanosine—Pain—Estradiol—prostate cancer	0.000621	0.000842	CcSEcCtD
Didanosine—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000621	0.000842	CcSEcCtD
Didanosine—Neuropathy peripheral—Prednisone—prostate cancer	0.00062	0.000841	CcSEcCtD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	0.000619	0.00493	CbGpPWpGaD
Didanosine—Leukopenia—Etoposide—prostate cancer	0.000618	0.000837	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000617	0.000836	CcSEcCtD
Didanosine—Anaphylactoid reaction—Doxorubicin—prostate cancer	0.000614	0.000832	CcSEcCtD
Didanosine—Hypoglycaemia—Doxorubicin—prostate cancer	0.000609	0.000825	CcSEcCtD
Didanosine—Paraesthesia—Mitoxantrone—prostate cancer	0.000608	0.000824	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000596	0.00475	CbGpPWpGaD
Didanosine—Dyspepsia—Mitoxantrone—prostate cancer	0.000596	0.000808	CcSEcCtD
Didanosine—Gastrointestinal pain—Estradiol—prostate cancer	0.000594	0.000805	CcSEcCtD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.000593	0.00473	CbGpPWpGaD
Didanosine—Chills—Docetaxel—prostate cancer	0.000591	0.000801	CcSEcCtD
Didanosine—Decreased appetite—Mitoxantrone—prostate cancer	0.000588	0.000798	CcSEcCtD
Didanosine—PNP—Metabolism—TNFRSF21—prostate cancer	0.000588	0.00468	CbGpPWpGaD
Didanosine—Abdominal pain upper—Epirubicin—prostate cancer	0.000587	0.000795	CcSEcCtD
Didanosine—Vomiting—Goserelin—prostate cancer	0.000583	0.00079	CcSEcCtD
Didanosine—Alopecia—Docetaxel—prostate cancer	0.000582	0.000789	CcSEcCtD
Didanosine—Discomfort—Etoposide—prostate cancer	0.00058	0.000787	CcSEcCtD
Didanosine—Pain—Mitoxantrone—prostate cancer	0.000579	0.000785	CcSEcCtD
Didanosine—Rash—Goserelin—prostate cancer	0.000578	0.000783	CcSEcCtD
Didanosine—Dermatitis—Goserelin—prostate cancer	0.000577	0.000782	CcSEcCtD
Didanosine—Vomiting—Conjugated Estrogens—prostate cancer	0.000577	0.000782	CcSEcCtD
Didanosine—Abdominal pain—Estradiol—prostate cancer	0.000574	0.000778	CcSEcCtD
Didanosine—Body temperature increased—Estradiol—prostate cancer	0.000574	0.000778	CcSEcCtD
Didanosine—Headache—Goserelin—prostate cancer	0.000574	0.000778	CcSEcCtD
Didanosine—Rash—Conjugated Estrogens—prostate cancer	0.000572	0.000776	CcSEcCtD
Didanosine—Chills—Capecitabine—prostate cancer	0.000572	0.000776	CcSEcCtD
Didanosine—PNP—Metabolism—MTAP—prostate cancer	0.000572	0.00456	CbGpPWpGaD
Didanosine—PNP—Metabolism—CYP7B1—prostate cancer	0.000572	0.00456	CbGpPWpGaD
Didanosine—Dermatitis—Conjugated Estrogens—prostate cancer	0.000572	0.000775	CcSEcCtD
Didanosine—Headache—Conjugated Estrogens—prostate cancer	0.000569	0.000771	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000567	0.00452	CbGpPWpGaD
Didanosine—Alopecia—Capecitabine—prostate cancer	0.000564	0.000764	CcSEcCtD
Didanosine—Anaphylactic shock—Etoposide—prostate cancer	0.000563	0.000763	CcSEcCtD
Didanosine—Infection—Etoposide—prostate cancer	0.000559	0.000758	CcSEcCtD
Didanosine—PNP—Metabolism—SULT1E1—prostate cancer	0.000557	0.00444	CbGpPWpGaD
Didanosine—PNP—Metabolism—SRD5A1—prostate cancer	0.000557	0.00444	CbGpPWpGaD
Didanosine—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000554	0.00075	CcSEcCtD
Didanosine—Thrombocytopenia—Etoposide—prostate cancer	0.000551	0.000747	CcSEcCtD
Didanosine—Flatulence—Capecitabine—prostate cancer	0.000547	0.000741	CcSEcCtD
Didanosine—Nausea—Goserelin—prostate cancer	0.000544	0.000738	CcSEcCtD
Didanosine—Pancreatitis—Epirubicin—prostate cancer	0.000544	0.000738	CcSEcCtD
Didanosine—Abdominal pain upper—Doxorubicin—prostate cancer	0.000543	0.000736	CcSEcCtD
Didanosine—Nausea—Conjugated Estrogens—prostate cancer	0.000539	0.000731	CcSEcCtD
Didanosine—Anorexia—Etoposide—prostate cancer	0.000537	0.000727	CcSEcCtD
Didanosine—Hypersensitivity—Estradiol—prostate cancer	0.000535	0.000725	CcSEcCtD
Didanosine—Abdominal pain—Mitoxantrone—prostate cancer	0.000535	0.000725	CcSEcCtD
Didanosine—Body temperature increased—Mitoxantrone—prostate cancer	0.000535	0.000725	CcSEcCtD
Didanosine—PNP—Metabolism—HSD17B3—prostate cancer	0.000532	0.00424	CbGpPWpGaD
Didanosine—PNP—Metabolism—ACSL4—prostate cancer	0.000532	0.00424	CbGpPWpGaD
Didanosine—Anaemia—Docetaxel—prostate cancer	0.00053	0.000718	CcSEcCtD
Didanosine—Asthenia—Estradiol—prostate cancer	0.000521	0.000706	CcSEcCtD
Didanosine—Pruritus—Estradiol—prostate cancer	0.000514	0.000697	CcSEcCtD
Didanosine—Leukopenia—Docetaxel—prostate cancer	0.000513	0.000696	CcSEcCtD
Didanosine—Anaemia—Capecitabine—prostate cancer	0.000513	0.000695	CcSEcCtD
Didanosine—PNP—Metabolism—ARG2—prostate cancer	0.00051	0.00406	CbGpPWpGaD
Didanosine—PNP—Metabolism—PHGDH—prostate cancer	0.00051	0.00406	CbGpPWpGaD
Didanosine—PNP—Metabolism—UMPS—prostate cancer	0.00051	0.00406	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000507	0.00404	CbGpPWpGaD
Didanosine—Paraesthesia—Etoposide—prostate cancer	0.000506	0.000685	CcSEcCtD
Didanosine—Pancreatitis—Doxorubicin—prostate cancer	0.000504	0.000682	CcSEcCtD
Didanosine—Alopecia—Prednisone—prostate cancer	0.000502	0.00068	CcSEcCtD
Didanosine—Hyperglycaemia—Epirubicin—prostate cancer	0.000501	0.000679	CcSEcCtD
Didanosine—Malaise—Capecitabine—prostate cancer	0.000501	0.000679	CcSEcCtD
Didanosine—PNP—Metabolism—LDHB—prostate cancer	0.0005	0.00398	CbGpPWpGaD
Didanosine—Hypersensitivity—Mitoxantrone—prostate cancer	0.000499	0.000676	CcSEcCtD
Didanosine—Diarrhoea—Estradiol—prostate cancer	0.000497	0.000674	CcSEcCtD
Didanosine—Leukopenia—Capecitabine—prostate cancer	0.000497	0.000673	CcSEcCtD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.000492	0.00392	CbGpPWpGaD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.000492	0.00392	CbGpPWpGaD
Didanosine—PNP—Metabolism—CYP3A5—prostate cancer	0.000491	0.00391	CbGpPWpGaD
Didanosine—Decreased appetite—Etoposide—prostate cancer	0.000489	0.000663	CcSEcCtD
Didanosine—Arthralgia—Docetaxel—prostate cancer	0.000488	0.000662	CcSEcCtD
Didanosine—Myalgia—Docetaxel—prostate cancer	0.000488	0.000662	CcSEcCtD
Didanosine—Asthenia—Mitoxantrone—prostate cancer	0.000486	0.000658	CcSEcCtD
Didanosine—Neuropathy peripheral—Epirubicin—prostate cancer	0.000485	0.000657	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000484	0.00385	CbGpPWpGaD
Didanosine—Pain—Etoposide—prostate cancer	0.000482	0.000653	CcSEcCtD
Didanosine—Dry mouth—Docetaxel—prostate cancer	0.000477	0.000647	CcSEcCtD
Didanosine—PNP—Metabolism—PDHA1—prostate cancer	0.000474	0.00378	CbGpPWpGaD
Didanosine—PNP—Metabolism—GSTA3—prostate cancer	0.000474	0.00378	CbGpPWpGaD
Didanosine—PNP—Metabolism—UCP3—prostate cancer	0.000474	0.00378	CbGpPWpGaD
Didanosine—PNP—Metabolism—TCN2—prostate cancer	0.000474	0.00378	CbGpPWpGaD
Didanosine—Arthralgia—Capecitabine—prostate cancer	0.000473	0.000641	CcSEcCtD
Didanosine—Myalgia—Capecitabine—prostate cancer	0.000473	0.000641	CcSEcCtD
Didanosine—Hepatobiliary disease—Epirubicin—prostate cancer	0.000468	0.000634	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000468	0.00373	CbGpPWpGaD
Didanosine—Anaphylactic shock—Docetaxel—prostate cancer	0.000468	0.000634	CcSEcCtD
Didanosine—Discomfort—Capecitabine—prostate cancer	0.000467	0.000633	CcSEcCtD
Didanosine—Infection—Docetaxel—prostate cancer	0.000465	0.00063	CcSEcCtD
Didanosine—Hyperglycaemia—Doxorubicin—prostate cancer	0.000463	0.000628	CcSEcCtD
Didanosine—Diarrhoea—Mitoxantrone—prostate cancer	0.000463	0.000628	CcSEcCtD
Didanosine—Dry mouth—Capecitabine—prostate cancer	0.000462	0.000626	CcSEcCtD
Didanosine—Vomiting—Estradiol—prostate cancer	0.000462	0.000626	CcSEcCtD
Didanosine—Agranulocytosis—Epirubicin—prostate cancer	0.000462	0.000626	CcSEcCtD
Didanosine—Gastrointestinal pain—Etoposide—prostate cancer	0.00046	0.000624	CcSEcCtD
Didanosine—Thrombocytopenia—Docetaxel—prostate cancer	0.000458	0.000621	CcSEcCtD
Didanosine—Rash—Estradiol—prostate cancer	0.000458	0.000621	CcSEcCtD
Didanosine—Dermatitis—Estradiol—prostate cancer	0.000458	0.00062	CcSEcCtD
Didanosine—Anaemia—Prednisone—prostate cancer	0.000457	0.000619	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000456	0.00363	CbGpPWpGaD
Didanosine—Headache—Estradiol—prostate cancer	0.000455	0.000617	CcSEcCtD
Didanosine—PNP—Metabolism—SLC22A3—prostate cancer	0.000452	0.0036	CbGpPWpGaD
Didanosine—PNP—Metabolism—HSD3B1—prostate cancer	0.000452	0.0036	CbGpPWpGaD
Didanosine—Infection—Capecitabine—prostate cancer	0.00045	0.00061	CcSEcCtD
Didanosine—Neuropathy peripheral—Doxorubicin—prostate cancer	0.000449	0.000608	CcSEcCtD
Didanosine—Anorexia—Docetaxel—prostate cancer	0.000446	0.000605	CcSEcCtD
Didanosine—Malaise—Prednisone—prostate cancer	0.000446	0.000604	CcSEcCtD
Didanosine—Body temperature increased—Etoposide—prostate cancer	0.000445	0.000603	CcSEcCtD
Didanosine—Abdominal pain—Etoposide—prostate cancer	0.000445	0.000603	CcSEcCtD
Didanosine—Hepatitis—Epirubicin—prostate cancer	0.000444	0.000602	CcSEcCtD
Didanosine—Thrombocytopenia—Capecitabine—prostate cancer	0.000444	0.000601	CcSEcCtD
Didanosine—Hypoaesthesia—Epirubicin—prostate cancer	0.000442	0.000599	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000435	0.00347	CbGpPWpGaD
Didanosine—PNP—Metabolism—TBXAS1—prostate cancer	0.000433	0.00345	CbGpPWpGaD
Didanosine—PNP—Metabolism—GSTA4—prostate cancer	0.000433	0.00345	CbGpPWpGaD
Didanosine—Hepatobiliary disease—Doxorubicin—prostate cancer	0.000433	0.000587	CcSEcCtD
Didanosine—Anorexia—Capecitabine—prostate cancer	0.000432	0.000585	CcSEcCtD
Didanosine—Nausea—Estradiol—prostate cancer	0.000432	0.000585	CcSEcCtD
Didanosine—Vomiting—Mitoxantrone—prostate cancer	0.00043	0.000583	CcSEcCtD
Didanosine—Agranulocytosis—Doxorubicin—prostate cancer	0.000427	0.000579	CcSEcCtD
Didanosine—Rash—Mitoxantrone—prostate cancer	0.000427	0.000578	CcSEcCtD
Didanosine—Dermatitis—Mitoxantrone—prostate cancer	0.000426	0.000578	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000426	0.000578	CcSEcCtD
Didanosine—Headache—Mitoxantrone—prostate cancer	0.000424	0.000575	CcSEcCtD
Didanosine—PNP—Metabolism—GSTA2—prostate cancer	0.000422	0.00336	CbGpPWpGaD
Didanosine—Arthralgia—Prednisone—prostate cancer	0.000421	0.000571	CcSEcCtD
Didanosine—Myalgia—Prednisone—prostate cancer	0.000421	0.000571	CcSEcCtD
Didanosine—Paraesthesia—Docetaxel—prostate cancer	0.00042	0.00057	CcSEcCtD
Didanosine—PNP—Metabolism—SULT1A1—prostate cancer	0.000417	0.00332	CbGpPWpGaD
Didanosine—PNP—Metabolism—ABCG5—prostate cancer	0.000417	0.00332	CbGpPWpGaD
Didanosine—Discomfort—Prednisone—prostate cancer	0.000416	0.000564	CcSEcCtD
Didanosine—Hypersensitivity—Etoposide—prostate cancer	0.000415	0.000562	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000413	0.00329	CbGpPWpGaD
Didanosine—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000413	0.000559	CcSEcCtD
Didanosine—Dyspepsia—Docetaxel—prostate cancer	0.000412	0.000558	CcSEcCtD
Didanosine—Hepatitis—Doxorubicin—prostate cancer	0.000411	0.000557	CcSEcCtD
Didanosine—Hypoaesthesia—Doxorubicin—prostate cancer	0.000409	0.000554	CcSEcCtD
Didanosine—PNP—Metabolism—GSTA1—prostate cancer	0.000408	0.00325	CbGpPWpGaD
Didanosine—Paraesthesia—Capecitabine—prostate cancer	0.000407	0.000551	CcSEcCtD
Didanosine—Decreased appetite—Docetaxel—prostate cancer	0.000407	0.000551	CcSEcCtD
Didanosine—Asthenia—Etoposide—prostate cancer	0.000404	0.000548	CcSEcCtD
Didanosine—Anaphylactic shock—Prednisone—prostate cancer	0.000404	0.000547	CcSEcCtD
Didanosine—PNP—Metabolism—NAT2—prostate cancer	0.000403	0.00321	CbGpPWpGaD
Didanosine—PNP—Metabolism—HSD3B2—prostate cancer	0.000403	0.00321	CbGpPWpGaD
Didanosine—PNP—Metabolism—GSTO1—prostate cancer	0.000403	0.00321	CbGpPWpGaD
Didanosine—PNP—Clobetasol propionate—Prednisone—prostate cancer	0.000403	0.0164	CbGdCrCtD
Didanosine—Nausea—Mitoxantrone—prostate cancer	0.000402	0.000545	CcSEcCtD
Didanosine—Infection—Prednisone—prostate cancer	0.000401	0.000543	CcSEcCtD
Didanosine—Pain—Docetaxel—prostate cancer	0.0004	0.000542	CcSEcCtD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.000399	0.00318	CbGpPWpGaD
Didanosine—Dyspepsia—Capecitabine—prostate cancer	0.000399	0.000541	CcSEcCtD
Didanosine—Chills—Epirubicin—prostate cancer	0.000399	0.00054	CcSEcCtD
Didanosine—Pruritus—Etoposide—prostate cancer	0.000398	0.00054	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000398	0.00317	CbGpPWpGaD
Didanosine—PNP—Flunisolide—Prednisone—prostate cancer	0.000397	0.0161	CbGdCrCtD
Didanosine—Decreased appetite—Capecitabine—prostate cancer	0.000394	0.000534	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000393	0.00313	CbGpPWpGaD
Didanosine—Alopecia—Epirubicin—prostate cancer	0.000393	0.000532	CcSEcCtD
Didanosine—Pain—Capecitabine—prostate cancer	0.000387	0.000525	CcSEcCtD
Didanosine—PNP—Metabolism—CYP2C18—prostate cancer	0.000386	0.00308	CbGpPWpGaD
Didanosine—PNP—Metabolism—PLCB2—prostate cancer	0.000386	0.00308	CbGpPWpGaD
Didanosine—PNP—Metabolism—LRP2—prostate cancer	0.000386	0.00308	CbGpPWpGaD
Didanosine—Diarrhoea—Etoposide—prostate cancer	0.000385	0.000522	CcSEcCtD
Didanosine—Anorexia—Prednisone—prostate cancer	0.000385	0.000521	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000384	0.00306	CbGpPWpGaD
Didanosine—Gastrointestinal pain—Docetaxel—prostate cancer	0.000383	0.000519	CcSEcCtD
Didanosine—Flatulence—Epirubicin—prostate cancer	0.000381	0.000517	CcSEcCtD
Didanosine—PNP—Metabolism—P4HB—prostate cancer	0.000379	0.00302	CbGpPWpGaD
Didanosine—Gastrointestinal pain—Capecitabine—prostate cancer	0.00037	0.000502	CcSEcCtD
Didanosine—Body temperature increased—Docetaxel—prostate cancer	0.00037	0.000501	CcSEcCtD
Didanosine—Abdominal pain—Docetaxel—prostate cancer	0.00037	0.000501	CcSEcCtD
Didanosine—Chills—Doxorubicin—prostate cancer	0.000369	0.0005	CcSEcCtD
Didanosine—PNP—Metabolism—SLC22A1—prostate cancer	0.000369	0.00294	CbGpPWpGaD
Didanosine—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000368	0.000498	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000366	0.00291	CbGpPWpGaD
Didanosine—Alopecia—Doxorubicin—prostate cancer	0.000363	0.000492	CcSEcCtD
Didanosine—Paraesthesia—Prednisone—prostate cancer	0.000362	0.000491	CcSEcCtD
Didanosine—PNP—Metabolism—SULT2A1—prostate cancer	0.000359	0.00286	CbGpPWpGaD
Didanosine—Abdominal pain—Capecitabine—prostate cancer	0.000358	0.000485	CcSEcCtD
Didanosine—Body temperature increased—Capecitabine—prostate cancer	0.000358	0.000485	CcSEcCtD
Didanosine—Vomiting—Etoposide—prostate cancer	0.000358	0.000485	CcSEcCtD
Didanosine—Anaemia—Epirubicin—prostate cancer	0.000357	0.000484	CcSEcCtD
Didanosine—Dyspepsia—Prednisone—prostate cancer	0.000355	0.000481	CcSEcCtD
Didanosine—Rash—Etoposide—prostate cancer	0.000355	0.000481	CcSEcCtD
Didanosine—Dermatitis—Etoposide—prostate cancer	0.000355	0.000481	CcSEcCtD
Didanosine—PNP—Metabolism—MED12—prostate cancer	0.000353	0.00281	CbGpPWpGaD
Didanosine—Headache—Etoposide—prostate cancer	0.000353	0.000478	CcSEcCtD
Didanosine—Flatulence—Doxorubicin—prostate cancer	0.000353	0.000478	CcSEcCtD
Didanosine—Decreased appetite—Prednisone—prostate cancer	0.000351	0.000475	CcSEcCtD
Didanosine—PNP—Metabolism—GNG5—prostate cancer	0.000351	0.00279	CbGpPWpGaD
Didanosine—Malaise—Epirubicin—prostate cancer	0.000349	0.000473	CcSEcCtD
Didanosine—Leukopenia—Epirubicin—prostate cancer	0.000346	0.000469	CcSEcCtD
Didanosine—Hypersensitivity—Docetaxel—prostate cancer	0.000345	0.000467	CcSEcCtD
Didanosine—PNP—Metabolism—NCOA3—prostate cancer	0.000338	0.00269	CbGpPWpGaD
Didanosine—Asthenia—Docetaxel—prostate cancer	0.000336	0.000455	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000335	0.00267	CbGpPWpGaD
Didanosine—Nausea—Etoposide—prostate cancer	0.000334	0.000453	CcSEcCtD
Didanosine—Hypersensitivity—Capecitabine—prostate cancer	0.000334	0.000452	CcSEcCtD
Didanosine—Pruritus—Docetaxel—prostate cancer	0.000331	0.000449	CcSEcCtD
Didanosine—Anaemia—Doxorubicin—prostate cancer	0.000331	0.000448	CcSEcCtD
Didanosine—Gastrointestinal pain—Prednisone—prostate cancer	0.00033	0.000447	CcSEcCtD
Didanosine—Myalgia—Epirubicin—prostate cancer	0.000329	0.000446	CcSEcCtD
Didanosine—Arthralgia—Epirubicin—prostate cancer	0.000329	0.000446	CcSEcCtD
Didanosine—Discomfort—Epirubicin—prostate cancer	0.000325	0.000441	CcSEcCtD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.000325	0.00259	CbGpPWpGaD
Didanosine—Asthenia—Capecitabine—prostate cancer	0.000325	0.000441	CcSEcCtD
Didanosine—Malaise—Doxorubicin—prostate cancer	0.000323	0.000437	CcSEcCtD
Didanosine—PNP—Metabolism—HPGDS—prostate cancer	0.000322	0.00257	CbGpPWpGaD
Didanosine—Dry mouth—Epirubicin—prostate cancer	0.000322	0.000436	CcSEcCtD
Didanosine—Pruritus—Capecitabine—prostate cancer	0.000321	0.000434	CcSEcCtD
Didanosine—Leukopenia—Doxorubicin—prostate cancer	0.00032	0.000434	CcSEcCtD
Didanosine—Diarrhoea—Docetaxel—prostate cancer	0.00032	0.000434	CcSEcCtD
Didanosine—PNP—Metabolism—CYP2C19—prostate cancer	0.00032	0.00255	CbGpPWpGaD
Didanosine—Abdominal pain—Prednisone—prostate cancer	0.000319	0.000432	CcSEcCtD
Didanosine—Body temperature increased—Prednisone—prostate cancer	0.000319	0.000432	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000316	0.00252	CbGpPWpGaD
Didanosine—Anaphylactic shock—Epirubicin—prostate cancer	0.000316	0.000428	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000315	0.00251	CbGpPWpGaD
Didanosine—Infection—Epirubicin—prostate cancer	0.000314	0.000425	CcSEcCtD
Didanosine—PNP—Metabolism—GSTT1—prostate cancer	0.000312	0.00249	CbGpPWpGaD
Didanosine—PNP—Metabolism—ACHE—prostate cancer	0.000312	0.00249	CbGpPWpGaD
Didanosine—Diarrhoea—Capecitabine—prostate cancer	0.00031	0.00042	CcSEcCtD
Didanosine—Thrombocytopenia—Epirubicin—prostate cancer	0.000309	0.000419	CcSEcCtD
Didanosine—PNP—Metabolism—CYP2A6—prostate cancer	0.000309	0.00246	CbGpPWpGaD
Didanosine—Myalgia—Doxorubicin—prostate cancer	0.000305	0.000413	CcSEcCtD
Didanosine—Arthralgia—Doxorubicin—prostate cancer	0.000305	0.000413	CcSEcCtD
Didanosine—PNP—Danazol—Prednisone—prostate cancer	0.000304	0.0124	CbGdCrCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000302	0.0024	CbGpPWpGaD
Didanosine—Discomfort—Doxorubicin—prostate cancer	0.000301	0.000408	CcSEcCtD
Didanosine—Anorexia—Epirubicin—prostate cancer	0.000301	0.000408	CcSEcCtD
Didanosine—PNP—Metabolism—AKR1C3—prostate cancer	0.0003	0.00239	CbGpPWpGaD
Didanosine—PNP—Metabolism—PRKACB—prostate cancer	0.000299	0.00238	CbGpPWpGaD
Didanosine—Dry mouth—Doxorubicin—prostate cancer	0.000298	0.000404	CcSEcCtD
Didanosine—Vomiting—Docetaxel—prostate cancer	0.000298	0.000403	CcSEcCtD
Didanosine—Hypersensitivity—Prednisone—prostate cancer	0.000297	0.000403	CcSEcCtD
Didanosine—PNP—Metabolism—CYP17A1—prostate cancer	0.000296	0.00236	CbGpPWpGaD
Didanosine—Rash—Docetaxel—prostate cancer	0.000295	0.0004	CcSEcCtD
Didanosine—Dermatitis—Docetaxel—prostate cancer	0.000295	0.0004	CcSEcCtD
Didanosine—Headache—Docetaxel—prostate cancer	0.000293	0.000397	CcSEcCtD
Didanosine—Anaphylactic shock—Doxorubicin—prostate cancer	0.000292	0.000396	CcSEcCtD
Didanosine—Infection—Doxorubicin—prostate cancer	0.00029	0.000393	CcSEcCtD
Didanosine—Asthenia—Prednisone—prostate cancer	0.00029	0.000392	CcSEcCtD
Didanosine—Vomiting—Capecitabine—prostate cancer	0.000288	0.00039	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000288	0.00039	CcSEcCtD
Didanosine—Thrombocytopenia—Doxorubicin—prostate cancer	0.000286	0.000388	CcSEcCtD
Didanosine—Rash—Capecitabine—prostate cancer	0.000286	0.000387	CcSEcCtD
Didanosine—Pruritus—Prednisone—prostate cancer	0.000286	0.000387	CcSEcCtD
Didanosine—Dermatitis—Capecitabine—prostate cancer	0.000285	0.000387	CcSEcCtD
Didanosine—Headache—Capecitabine—prostate cancer	0.000284	0.000385	CcSEcCtD
Didanosine—Paraesthesia—Epirubicin—prostate cancer	0.000283	0.000384	CcSEcCtD
Didanosine—PNP—Metabolism—NCOA2—prostate cancer	0.000282	0.00225	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000279	0.00222	CbGpPWpGaD
Didanosine—Anorexia—Doxorubicin—prostate cancer	0.000278	0.000377	CcSEcCtD
Didanosine—Nausea—Docetaxel—prostate cancer	0.000278	0.000377	CcSEcCtD
Didanosine—Dyspepsia—Epirubicin—prostate cancer	0.000278	0.000377	CcSEcCtD
Didanosine—Diarrhoea—Prednisone—prostate cancer	0.000276	0.000374	CcSEcCtD
Didanosine—Decreased appetite—Epirubicin—prostate cancer	0.000274	0.000372	CcSEcCtD
Didanosine—Pain—Epirubicin—prostate cancer	0.00027	0.000366	CcSEcCtD
Didanosine—Nausea—Capecitabine—prostate cancer	0.000269	0.000365	CcSEcCtD
Didanosine—PNP—Metabolism—SLC5A5—prostate cancer	0.000269	0.00214	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000266	0.00212	CbGpPWpGaD
Didanosine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.000266	0.000361	CcSEcCtD
Didanosine—PNP—Metabolism—CYP2E1—prostate cancer	0.000263	0.00209	CbGpPWpGaD
Didanosine—Paraesthesia—Doxorubicin—prostate cancer	0.000262	0.000355	CcSEcCtD
Didanosine—PNP—Metabolism—NQO1—prostate cancer	0.00026	0.00207	CbGpPWpGaD
Didanosine—Gastrointestinal pain—Epirubicin—prostate cancer	0.000258	0.00035	CcSEcCtD
Didanosine—Dyspepsia—Doxorubicin—prostate cancer	0.000257	0.000348	CcSEcCtD
Didanosine—Vomiting—Prednisone—prostate cancer	0.000257	0.000348	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000256	0.00204	CbGpPWpGaD
Didanosine—PNP—Metabolism—TH—prostate cancer	0.000256	0.00204	CbGpPWpGaD
Didanosine—Rash—Prednisone—prostate cancer	0.000254	0.000345	CcSEcCtD
Didanosine—Dermatitis—Prednisone—prostate cancer	0.000254	0.000345	CcSEcCtD
Didanosine—Decreased appetite—Doxorubicin—prostate cancer	0.000254	0.000344	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000253	0.00202	CbGpPWpGaD
Didanosine—PNP—Metabolism—CYP3A4—prostate cancer	0.000253	0.00202	CbGpPWpGaD
Didanosine—Headache—Prednisone—prostate cancer	0.000253	0.000343	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.00025	0.00199	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.00025	0.00199	CbGpPWpGaD
Didanosine—Pain—Doxorubicin—prostate cancer	0.00025	0.000338	CcSEcCtD
Didanosine—Abdominal pain—Epirubicin—prostate cancer	0.00025	0.000338	CcSEcCtD
Didanosine—Body temperature increased—Epirubicin—prostate cancer	0.00025	0.000338	CcSEcCtD
Didanosine—PNP—Metabolism—CYP1B1—prostate cancer	0.000249	0.00198	CbGpPWpGaD
Didanosine—PNP—Metabolism—GGT1—prostate cancer	0.000241	0.00192	CbGpPWpGaD
Didanosine—Nausea—Prednisone—prostate cancer	0.00024	0.000325	CcSEcCtD
Didanosine—Gastrointestinal pain—Doxorubicin—prostate cancer	0.000239	0.000324	CcSEcCtD
Didanosine—PNP—Metabolism—NCOA1—prostate cancer	0.000237	0.00189	CbGpPWpGaD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.000237	0.00189	CbGpPWpGaD
Didanosine—PNP—Metabolism—CYP19A1—prostate cancer	0.000234	0.00186	CbGpPWpGaD
Didanosine—Hypersensitivity—Epirubicin—prostate cancer	0.000233	0.000315	CcSEcCtD
Didanosine—Body temperature increased—Doxorubicin—prostate cancer	0.000231	0.000313	CcSEcCtD
Didanosine—Abdominal pain—Doxorubicin—prostate cancer	0.000231	0.000313	CcSEcCtD
Didanosine—Asthenia—Epirubicin—prostate cancer	0.000226	0.000307	CcSEcCtD
Didanosine—PNP—Metabolism—RXRA—prostate cancer	0.000226	0.0018	CbGpPWpGaD
Didanosine—Pruritus—Epirubicin—prostate cancer	0.000223	0.000303	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000222	0.00177	CbGpPWpGaD
Didanosine—PNP—Metabolism—COMT—prostate cancer	0.000218	0.00173	CbGpPWpGaD
Didanosine—PNP—Metabolism—GSTP1—prostate cancer	0.000217	0.00173	CbGpPWpGaD
Didanosine—Diarrhoea—Epirubicin—prostate cancer	0.000216	0.000293	CcSEcCtD
Didanosine—Hypersensitivity—Doxorubicin—prostate cancer	0.000215	0.000292	CcSEcCtD
Didanosine—PNP—Metabolism—ITPR1—prostate cancer	0.000213	0.0017	CbGpPWpGaD
Didanosine—Asthenia—Doxorubicin—prostate cancer	0.00021	0.000284	CcSEcCtD
Didanosine—Pruritus—Doxorubicin—prostate cancer	0.000207	0.00028	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000203	0.00161	CbGpPWpGaD
Didanosine—PNP—Metabolism—TYMS—prostate cancer	0.000201	0.0016	CbGpPWpGaD
Didanosine—Vomiting—Epirubicin—prostate cancer	0.000201	0.000272	CcSEcCtD
Didanosine—Diarrhoea—Doxorubicin—prostate cancer	0.0002	0.000271	CcSEcCtD
Didanosine—PNP—Metabolism—GSTM1—prostate cancer	0.000199	0.00159	CbGpPWpGaD
Didanosine—Rash—Epirubicin—prostate cancer	0.000199	0.00027	CcSEcCtD
Didanosine—Dermatitis—Epirubicin—prostate cancer	0.000199	0.000269	CcSEcCtD
Didanosine—Headache—Epirubicin—prostate cancer	0.000198	0.000268	CcSEcCtD
Didanosine—PNP—Metabolism—LPL—prostate cancer	0.000195	0.00156	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000194	0.00154	CbGpPWpGaD
Didanosine—PNP—Metabolism—CYP1A1—prostate cancer	0.000189	0.0015	CbGpPWpGaD
Didanosine—Nausea—Epirubicin—prostate cancer	0.000187	0.000254	CcSEcCtD
Didanosine—PNP—Metabolism—ERCC2—prostate cancer	0.000187	0.00149	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000187	0.00149	CbGpPWpGaD
Didanosine—Vomiting—Doxorubicin—prostate cancer	0.000186	0.000252	CcSEcCtD
Didanosine—Rash—Doxorubicin—prostate cancer	0.000184	0.00025	CcSEcCtD
Didanosine—Dermatitis—Doxorubicin—prostate cancer	0.000184	0.000249	CcSEcCtD
Didanosine—Headache—Doxorubicin—prostate cancer	0.000183	0.000248	CcSEcCtD
Didanosine—PNP—Metabolism—MTHFR—prostate cancer	0.000176	0.0014	CbGpPWpGaD
Didanosine—Nausea—Doxorubicin—prostate cancer	0.000173	0.000235	CcSEcCtD
Didanosine—PNP—Metabolism—PPARA—prostate cancer	0.000173	0.00137	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000165	0.00132	CbGpPWpGaD
Didanosine—PNP—Metabolism—CAV1—prostate cancer	0.000162	0.00129	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000157	0.00125	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000154	0.00122	CbGpPWpGaD
Didanosine—PNP—Metabolism—PIK3CG—prostate cancer	0.000148	0.00118	CbGpPWpGaD
Didanosine—PNP—Metabolism—INS—prostate cancer	0.00014	0.00111	CbGpPWpGaD
Didanosine—PNP—Metabolism—CREBBP—prostate cancer	0.000137	0.00109	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000134	0.00107	CbGpPWpGaD
Didanosine—PNP—Metabolism—PIK3CD—prostate cancer	0.00013	0.00103	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000126	0.00101	CbGpPWpGaD
Didanosine—PNP—Metabolism—NOS3—prostate cancer	0.000123	0.000977	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000121	0.00096	CbGpPWpGaD
Didanosine—PNP—Metabolism—PIK3CB—prostate cancer	0.000113	0.000902	CbGpPWpGaD
Didanosine—PNP—Metabolism—PTGS2—prostate cancer	0.000112	0.000894	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000106	0.000848	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000101	0.000807	CbGpPWpGaD
Didanosine—PNP—Metabolism—PTEN—prostate cancer	9.79e-05	0.000779	CbGpPWpGaD
Didanosine—PNP—Metabolism—EP300—prostate cancer	9.33e-05	0.000743	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—PPARA—prostate cancer	7.74e-05	0.000616	CbGpPWpGaD
Didanosine—PNP—Metabolism—PIK3CA—prostate cancer	6.9e-05	0.00055	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—CREBBP—prostate cancer	6.14e-05	0.000489	CbGpPWpGaD
Didanosine—PNP—Metabolism—AKT1—prostate cancer	5.64e-05	0.000449	CbGpPWpGaD
